These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3347936)

  • 21. Cyclosporine kinetics in renal transplantation.
    Ptachcinski RJ; Venkataramanan R; Rosenthal JT; Burckart GJ; Taylor RJ; Hakala TR
    Clin Pharmacol Ther; 1985 Sep; 38(3):296-300. PubMed ID: 3896612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclosporine disposition in the dog. Comparison of radioimmunoassay with high-performance liquid chromatographic assay and pharmacokinetics following intravenous administration.
    Buice RG; Gurley BJ; Stentz FB; Sidhu P; McClellan T; Williams JW
    Transplantation; 1985 Nov; 40(5):483-8. PubMed ID: 4060219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of two alternative dosage forms for cyclosporine: liposomes and intralipid.
    Venkataram S; Awni WM; Jordan K; Rahman YE
    J Pharm Sci; 1990 Mar; 79(3):216-9. PubMed ID: 2338629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Demographic factors affecting the pharmacokinetics of cyclosporine estimated by radioimmunoassay.
    Kahan BD; Kramer WG; Wideman C; Flechner SM; Lorber MI; Van Buren CT
    Transplantation; 1986 Apr; 41(4):459-64. PubMed ID: 3515645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of low and high density lipoproteins on renal cyclosporine A and cyclosporine G disposition in the isolated perfused rat kidney.
    Strong ML; Ueda CT
    Pharm Res; 1997 Oct; 14(10):1466-71. PubMed ID: 9358563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and nephrotoxicity of cyclosporine in renal transplant recipients.
    Henny FC; Kleinbloesem CH; Moolenaar AJ; Paul LC; Breimer DD; van Es LA
    Transplantation; 1985 Sep; 40(3):261-5. PubMed ID: 3898491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Area under the curve monitoring of cyclosporine therapy: the early posttransplant period.
    Grevel J; Kahan BD
    Ther Drug Monit; 1991 Mar; 13(2):89-95. PubMed ID: 2053129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of cyclosporin G (NVa2 cyclosporin) in blood and plasma.
    Yatscoff RW; Honcharik N; Lukowski M; Thliveris J; Chackowsky P; Faraci C
    Clin Chem; 1993 Feb; 39(2):213-7. PubMed ID: 8432008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of the immunosuppressive effects of cyclosporine A and cyclosporine G in vivo and in vitro.
    Rayat G; Yatscoff R; Silverman R; McKenna R
    Transplantation; 1993 Mar; 55(3):623-6. PubMed ID: 8456482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Canine liver transplantation under Nva2-cyclosporine versus cyclosporine.
    Todo S; Porter KA; Kam I; Lynch S; Venkataramanan R; DeWolf A; Starzl TE
    Transplantation; 1986 Mar; 41(3):296-300. PubMed ID: 3513388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics, inhibition of lymphoblast transformation, and toxicity of cyclosporine in clinically normal pigs.
    Vaden SL; Riviere JE
    Am J Vet Res; 1990 Mar; 51(3):399-403. PubMed ID: 2316917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-performance liquid chromatographic analysis of cyclosporin G (Nva2-cyclosporine) in human blood.
    Annesley TM; Matz K; Leichtman AB
    Ther Drug Monit; 1992 Oct; 14(5):397-401. PubMed ID: 1448848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of cyclosporine as a function of energy--protein deficiency in children with chronic renal failure.
    Lares-Asseff I; Zaltzman S; Pérez Guillé MG; Camacho GA; Murguía T; López MC; Toledo AR; Zaltzman-Rudy AB; Cravioto J
    J Clin Pharmacol; 1997 Mar; 37(3):179-85. PubMed ID: 9089419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term cyclosporine pharmacokinetic changes in renal transplant recipients: effects of binding and metabolism.
    Awni WM; Kasiske BL; Heim-Duthoy K; Rao KV
    Clin Pharmacol Ther; 1989 Jan; 45(1):41-8. PubMed ID: 2642778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclosporine analogues.
    Jeffery JR
    Clin Biochem; 1991 Feb; 24(1):15-21. PubMed ID: 2060128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trough levels and concentration time curves of cyclosporine in patients undergoing renal transplantation.
    Frey FJ; Horber FF; Frey BM
    Clin Pharmacol Ther; 1988 Jan; 43(1):55-62. PubMed ID: 3275522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum cyclosporine kinetic profile. Failure to correlate with nephrotoxicity or rejection episodes following sequential immunotherapy for renal transplantation.
    Sommer BG; Sing DE; Henry ML; Ferguson RM; Orosz CG
    Transplantation; 1988 Jan; 45(1):86-90. PubMed ID: 3276069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclosporin: pharmacokinetics and detailed studies of plasma and erythrocyte binding during intravenous and oral administration.
    Legg B; Gupta SK; Rowland M; Johnson RW; Solomon LR
    Eur J Clin Pharmacol; 1988; 34(5):451-60. PubMed ID: 3203704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective cross-over study comparing the pharmacokinetics of cyclosporine A and its metabolites after oral versus short-time intravenous cyclosporine A administration in pre-heart transplant patients.
    Lehle K; Kirchner GI; Rupprecht L; Gruber M; Birnbaum DE; Schmid FX; Preuner JG
    Transplant Proc; 2007 Dec; 39(10):3323-8. PubMed ID: 18089380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclosporine (cyclosporin A) pharmacokinetics in renal transplant patients receiving ciprofloxacin.
    Lang J; Finaz de Villaine J; Garraffo R; Touraine JL
    Am J Med; 1989 Nov; 87(5A):82S-85S. PubMed ID: 2589391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.